Education
About Us
Working with TipRanks
Follow Us
BioCorRx Inc (BICX)
OTHER OTC:BICX
BICX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.20 - $1.45
Previous CloseN/A
Volume44.00
Average Volume (3M)602.00
Market Cap
$6.62M
Enterprise Value$13.26M
Total Cash (Recent Filing)$111.87K
Total Debt (Recent Filing)$2.90M
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding18,911,995
10 Day Avg. Volume108
30 Day Avg. Volume602
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.00
Enterprise Value/Revenue42.35
Enterprise Value/Gross Profit40.88
Enterprise Value/Ebitda-3.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioCorRx News
BICX FAQ
What was BioCorRx Inc’s price range in the past 12 months?
BioCorRx Inc lowest stock price was $0.20 and its highest was $1.45 in the past 12 months.
What is BioCorRx Inc’s market cap?
BioCorRx Inc’s market cap is $6.62M.
When is BioCorRx Inc’s upcoming earnings report date?
BioCorRx Inc’s upcoming earnings report date is Aug 17, 2026 which is in 358 days.
How were BioCorRx Inc’s earnings last quarter?
BioCorRx Inc released its earnings results on Aug 14, 2025. The company reported -$0.072 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.072.
Is BioCorRx Inc overvalued?
According to Wall Street analysts BioCorRx Inc’s price is currently Overvalued.
Does BioCorRx Inc pay dividends?
BioCorRx Inc does not currently pay dividends.
What is BioCorRx Inc’s EPS estimate?
BioCorRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioCorRx Inc have?
BioCorRx Inc has 18,911,995 shares outstanding.
What happened to BioCorRx Inc’s price movement after its last earnings report?
BioCorRx Inc reported an EPS of -$0.072 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BioCorRx Inc?
Currently, no hedge funds are holding shares in BICX
Company Description
BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
Cryo-Cell International
―
Oncology Institute
―
COMPASS Pathways
―
Ownership Overview
Options Prices
Currently, No data available
---